Abstract:LCL161, a novel Smac mimetic, is known to have anti-tumor activity and improve chemosensitivity in various cancers. However, the function and mechanisms of the combination of LCL161 and paclitaxel in non-small cell lung cancer (NSCLC) remain unknown. Cellular inhibitor of apoptotic protein 1 and 2 (cIAP1 and cIAP2) expression in NSCLC tissues and adjacent non-tumor tissues were assessed by immunohistochemistry. The correlations between cIAP1,2 expression and clinicopathological characteristics, prognosis were analyzed. Cell viability and apoptosis were measured by MTT assays and Flow cytometry. Western blot and co-immunoprecipitation assay were performed to measure the protein expression and interaction in NF-κB pathway. siRNA-mediated gene silencing and caspases activity assays were applied to demonstrate the role and mechanisms of cIAP1,2 and RIP1 in lung cancer cell apoptosis. Mouse xenograft NSCLC models were used in vivo to determine the therapeutic efficacy of LCL161 alone or in combination with paclitaxel. The expression of cIAP1 and cIAP2 in Non-small cell lung cancer (NSCLC) tumors was significantly higher than that in adjacent normal tissues. cIAP1 was highly expressed in patients with late TNM stage NSCLC and a poor prognosis. Positivity for cIAP1 and cIAP2 was an independent prognostic factor that indicated a poorer prognosis in NSCLC patients. LCL161, an IAP inhibitor, cooperated with paclitaxel to reduce cell viability and induce apoptosis in NSCLC cells. Molecular studies revealed that paclitaxel increased TNFα expression, thereby leading to the recruitment of various factors and the formation of the TRADD-TRAF2-RIP1-cIAP complex. LCL161 degraded cIAP1 and cIAP2, releasing RIP1 from the complex. Subsequently, RIP1 was stabilized and bound to caspase-8 and FADD, thereby forming the caspase-8/RIP1/FADD complex, which activated caspase-8, caspase-3 and ultimately lead to apoptosis. In nude mouse xenograft experiments, the combination of LCL161 and paclitaxel degraded cIAP1,2, activated caspase-3 and inhibited tumor growth with few toxic effects. Thus, LCL161 could be a useful agent for the treatment of NSCLC in combination with paclitaxel.

The Role Of Ca2+ Signal Pathway In Apoptosis Of Sgc-7901 And Hepg2 Cells Induced By Paclitaxel

The Inhibiting Effect of Combination of Allicin with Paclitaxel on Proliferation of Gastric Cancer Cells and Promotion of Apoptosis

[Paclitaxel-Induced Apoptosis in ACC-2 Cells is Associated with the Arrest of G(2)/M].

The ClC-3 Chloride Channel Associated with Microtubules is a Target of Paclitaxel in Its Induced-Apoptosis

Nuclear Factor-Kappab/ikappab Signaling Pathway May Contribute to the Mediation of Paclitaxel-Induced Apoptosis in Solid Tumor Cells.

Paclitaxel Induce Apoptosis of Giant Cells Tumor of Bone Via TP53INP1 Signaling

The Possible Correlation Between Activation of NF-kappaB/IkappaB Pathway and the Susceptibility of Tumor Cells to Paclitaxel-Induced Apoptosis.

The Relationship Between P38mapk and Apoptosis During Paclitaxel Resistance of Ovarian Cancer Cells

Induction of caspase-3-dependent apoptosis in human leukemia HL-60 cells by paclitaxel.

Paclitaxel Induces Apoptosis in Human Gastric Carcinoma Cells

Inhibitory Effects of Paclitaxel on Human Embryonal Rhabdomyosarcoma Cell Line RD

Taxol induces concentration-dependent phosphatidylserine (PS) externalization and cell cycle arrest in ASTC-a-1 cells

Differential Gene Expression Profiles in Paclitaxel-Induced Cell Cycle Arrest and Apoptosis in Human Breast Cancer MCF-7 Cells.

Apoptosis Induced By Low-Dose Paclitaxel Is Associated With P53 Upregulation In Nasopharyngeal Carcinoma Cells

Apoptosis and Survivin mRNA expression of undifferential NPC cell line CNE-2 induced by Paclitaxel

P2.03a-059 LCL161 Increases Paclitaxel-Induced Apoptosis by Degrading Ciap1 and Ciap2 in NSCLC: Topic: Clinical Trials

Involvement of Mitochondrial Permeability Transition Pore Opening in 7-Xylosyl-10-deacetylpaclitaxel-induced Apoptosis.

Sequence-Dependent Potentiation of Paclitaxel-Mediated Apoptosis in Human Leukemia Cells by Inhibitors of the Mitogen-Activated Protein Kinase Kinase/Mitogen-Activated Protein Kinase Pathway

Possible mechanisms of paclitaxel-induced apoptosis.

Paclitaxel-Induced Apoptosis May Occur Without A Prior G(2)/M-Phase Arrest

IκB Kinase Activation is Involved in Regulation of Paclitaxel-Induced Apoptosis in Human Tumor Cell Lines